The expiration dates for certain lots of epinephrine injection, USP auto-injector 0.15mg and 0.3mg (Impax Laboratories), the authorized generic of Adrenaclick, have been extended by 2 months after the Company coordinated with the Food and Drug Administration (FDA) to address the ongoing drug shortage.
Epinephrine auto-injectors are indicated for the emergency treatment of allergic reactions (Type 1) including anaphylaxis. The expiration dates of these lots have been increased from 18 months to 20 months; the full list can be viewed here. “This announcement is made after a comprehensive evaluation of data to enable the extension of the expiration date on specific lots,” said Joseph Greer, SVP, Global Quality Management, in a press release.
Patients should continue to store the auto-injectors as labeled.
For more information visit FDA.gov.
This article originally appeared on MPR